{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:03:28Z","timestamp":1756425808772,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,6,30]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>A woman in her 30s received a second dose, first booster, Corminaty vaccine against the SARS-CoV-2. Three days later, the patient developed unilateral sacroiliitis. A pelvic scan revealed inflammatory joint edges, bone erosion and a heterogeneous mass of 2.5\u2009cm in the psoas muscle. Joint puncture revealed no microcrystalline deposits, but bone marrow cells, erythroblast were identified. The standard bacterial cultures and culture for mycobacteria were negative. HLA B27 was negative, and no seroconversion was identified for HIV, Epstein-Barr virus, cytomegalovirus, chlamydia or Quantiferon. Two months later, the sacroiliitis resolved.<\/jats:p>\n               <jats:p>The aetiologic approach of this erosive unilateral acute sacroiliitis in a person na\u00efve to rheumatologic pathology was negative for inflammatory or infectious sacroiliitis. Arthralgias after vaccination are expected. Arthritis is less common, and acute sacroiliitis has not yet been described. Acute sacroiliitis may be considered a reactive sacroiliitis to the anti-COVID-19 mRNA vaccine.<\/jats:p>","DOI":"10.1136\/bcr-2022-249063","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:15:11Z","timestamp":1657196111000},"page":"e249063","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Case of reactive sacroiliitis possibly induced by an mRNA coronavirus disease vaccine"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-1736","authenticated-orcid":false,"given":"Nicolas","family":"Roux","sequence":"first","affiliation":[{"name":"Rheumatology Department, UNEOS H\u00f4pitaux Priv\u00e9s de Metz, Metz-Vantoux, Lorraine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Poussing","sequence":"additional","affiliation":[{"name":"Biological Laboratory, UNEOS Hopitaux Prives de Metz, Metz, Lorraine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-8566","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Maurier","sequence":"additional","affiliation":[{"name":"Internal Medicine and Clinical Immunology Department, UNEOS Hopitaux Prives de Metz, Metz-Vantoux, Lorraine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.1","DOI":"10.1056\/nejmoa2026920"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.2","DOI":"10.1056\/NEJMOA2028436\/SUPPL_FILE\/NEJMOA2028436_DATA-SHARING.PDF"},{"key":"2025082801494193000_15.7.e249063.3","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 \u2014 preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.4","DOI":"10.1056\/NEJMoa2107456"},{"key":"2025082801494193000_15.7.e249063.5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.6","DOI":"10.1056\/NEJMoa2034577"},{"key":"2025082801494193000_15.7.e249063.7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination","volume":"385","author":"Barouch","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082801494193000_15.7.e249063.8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJMc2110716","article-title":"Heterologous ChAdOx1 nCoV-19 and mRNA-1273 vaccination","volume":"385","author":"Normark","year":"2021","journal-title":"N Engl J Med Overseas Ed"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.9","DOI":"10.1056\/NEJMoa2110475"},{"key":"2025082801494193000_15.7.e249063.10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and efficacy of NVX-CoV2373 Covid-19 vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.11","DOI":"10.1056\/NEJMoa2110362"},{"key":"2025082801494193000_15.7.e249063.12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082801494193000_15.7.e249063.13","doi-asserted-by":"crossref","first-page":"105086","DOI":"10.1016\/j.jbspin.2020.105086","article-title":"Can SARS-CoV-2 trigger reactive arthritis?","volume":"88","author":"Wendling","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2025082801494193000_15.7.e249063.14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/v13081558","article-title":"Post-COVID-19 arthritis and sacroiliitis: natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature","volume":"13","author":"Colatutto","year":"2021","journal-title":"Viruses"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.15","DOI":"10.1136\/annrheumdis-2020-218310"},{"doi-asserted-by":"publisher","key":"2025082801494193000_15.7.e249063.16","DOI":"10.1136\/annrheumdis-2021-221935"},{"key":"2025082801494193000_15.7.e249063.17","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e245","article-title":"Polyarthralgia and myalgia syndrome after ChAdOx1 nCOV-19 vaccination","volume":"36","author":"Hyun","year":"2021","journal-title":"J Korean Med Sci"},{"key":"2025082801494193000_15.7.e249063.18","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1080\/21645515.2021.1920274","article-title":"Reactive arthritis after COVID-19 vaccination","volume":"17","author":"QJ","year":"2021","journal-title":"Hum Vaccin Immunotherapy"},{"doi-asserted-by":"crossref","unstructured":"Baimukhamedov C . Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection (Sputnik-V). Int J Rheum Dis 2021.doi:10.1111\/1756-185X.14202","key":"2025082801494193000_15.7.e249063.19","DOI":"10.1111\/1756-185X.14202"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-249063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:49:49Z","timestamp":1756370989000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-249063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,7]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/bcr-2022-249063"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-249063","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}